Buried amongst the pandemic commotion was American Cancer Society’s newest cervical cancer screening guidelines. Cervical cancer affects women of all ages worldwide and is often dubbed ‘the silent killer’ as it presents with no symptoms in the early stages. Luckily there is an effective screening method to help reduce the…...
As Americans gathered around to watch the annual ball drop, most people were relieved to finally bid farewell to the unprecedented year of 2020. The year had been exceptionally challenging in every way imaginable – financially, physically, mentally, and emotionally. Though it was truly amazing to see people and organizations…...
From marriage proposals to politics, many topics are discussed around the holiday dinner table. This year, make sure to talk with your loved ones about your family health history to help better understand your unique health risks. The holiday season is approaching. As you get together with loved ones —…...
Oncoheroes Biosciences, a biotech focused on advancing new therapies for childhood cancer, recently announced that the Unites States Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) and Rare Pediatric Disease Designation (RPDD) to volasertib, one of its drugs. Volasertib is a small molecular inhibitor that has been…...
New approach developed by Dr. Rakesh Jain and his research team identifies biomarkers that may indicate which patients will best respond to immune checkpoint blockade therapies. A research team led by NFCR-supported scientist Rakesh K. Jain, PhD, the Andrew Werk Cook Professor of Tumor Biology at Harvard Medical School and…...
‘Tis the season for generosity as the holiday season reminds many families just how fortunate they are. As generosity and good tidings fill the crisp winter air, National Foundation for Cancer Research (NFCR) reminds people across the country of an easy yet impactful way to support an important cause: vehicle…...
FOR IMMEDIATE RELEASE: December 3, 2020 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Corporate Outreach E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 The Program is Designed to Catalyze and Advance Promising Cancer Research Innovations onto a Path of Commercialization and Patient Impact ROCKVILLE, MD – The National Foundation…...
Free Cancer Screening Guidelines
National Foundation for Cancer Research(NFCR) is a 501(c)(3) tax-exempt nonprofit organization.
Tax ID #: 04-2531031
5515 Security Lane, Suite 1105 Rockville, MD 20852
